Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Christopher J. Rini, Bruce C. Roberts, Aishwarya Vaidyanathan, Aojun Li, Rick Klug, Douglas B. Sherman & Ronald J. Pettis. (2022) Enabling faster subcutaneous delivery of larger volume, high viscosity fluids. Expert Opinion on Drug Delivery 19:9, pages 1165-1176.
Read now
Read now
Karin Luttropp, Johan Dalén, Axel Svedbom, Mary Dozier, Christopher M Black & Amy Puenpatom. (2020) Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review. Patient Preference and Adherence 14, pages 309-320.
Read now
Read now
Michael J. Visconti, Wasim Haidari & Steven R. Feldman. (2020) Transcutaneous electrical nerve stimulation (TENS): a review of applications in dermatology. Journal of Dermatological Treatment 31:8, pages 846-849.
Read now
Read now
Aurélie Pager, Anne Combedazou, Karen Guerrero, Tzvetelina Tzvetkova-Chevolleau, Didier Morel, Cécile Frolet & Stanislav Glezer. (2020) User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a staked 8 mm ultra-thin wall needle. Expert Opinion on Drug Delivery 17:10, pages 1485-1498.
Read now
Read now
Heather L Gelhorn, Zaneta Balantac, Christopher S Ambrose, Yen N Chung & Brian Stone. (2019) Patient and physician preferences for attributes of biologic medications for severe asthma. Patient Preference and Adherence 13, pages 1253-1268.
Read now
Read now
Fouad Fayad, Nelly R Ziade, Georges Merheb, Said Attoui, Alla Aiko, Kamel Mroue & Abdel Fattah Masri. (2018) Patient preferences for rheumatoid arthritis treatments: results from the national cross-sectional LERACS study. Patient Preference and Adherence 12, pages 1619-1625.
Read now
Read now
Mwangi J Murage, Vanita Tongbram, Steven R Feldman, William N Malatestinic, Cynthia J Larmore, Talia M Muram, Russel T Burge, Charles Bay, Nicole Johnson, Sarah Clifford & Andre B Araujo. (2018) Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Preference and Adherence 12, pages 1483-1503.
Read now
Read now
Ingrid Larsson. (2017) Patients’ conceptions of their own influence on good treatment response to biological therapy in chronic inflammatory arthritis. Patient Preference and Adherence 11, pages 1057-1067.
Read now
Read now
Axel Svedbom, Chiara Storck, Sumesh Kachroo, Marinella Govoni & Ahmed Khalifa. (2017) Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Patient Preference and Adherence 11, pages 719-729.
Read now
Read now
Susan C Bolge, Amir Goren, Duncan Brown, Seth Ginsberg & Isabel Allen. (2016) Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making. Patient Preference and Adherence 10, pages 1079-1090.
Read now
Read now
Kristina Callis Duffin, Michael Bukhalo, Margaret A Bobonich, David Shrom, Fangyi Zhao, James R Kershner, Anne Gill, Beth Pangallo, Catherine L Shuler & Jerry Bagel. (2016) Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience. Medical Devices: Evidence and Research 9, pages 361-369.
Read now
Read now
Andy R Fry, Andrew J Krentz & Marcus Hompesch. (2016) Considerations in biosimilar insulin device development. Biosimilars 6, pages 9-15.
Read now
Read now
Articles from other publishers (41)
Kyle Berman, Simon Moss, Barry Holden-Theunissen, Nobuhiko Satou, Kenji Okada, Mark Latymer & Attila Antalfy. (2023) Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies. Advances in Therapy 40:7, pages 3070-3086.
Crossref
Crossref
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T. Muriset, David Gruben & Mark Latymer. (2023) High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and Therapy 10:2, pages 477-487.
Crossref
Crossref
Edgar Akuffo-Addo, Theodora Udounwa, Jocelyn Chan & Laura Cauchi. (2022) Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review. Journal of Racial and Ethnic Health Disparities 10:2, pages 942-951.
Crossref
Crossref
Silvia Peretti, Sara Torracchi, Edda Russo, Francesco Bonomi, Elisa Fiorentini, Khadija El Aoufy, Cosimo Bruni, Gemma Lepri, Martina Orlandi, Maria Sole Chimenti, Serena Guiducci, Amedeo Amedei, Marco Matucci-Cerinic & Silvia Bellando Randone. (2022) The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review. Genes 14:1, pages 89.
Crossref
Crossref
Umut Mayetin & Serdar Kucuk. (2022) Design and Experimental Evaluation of a Low Cost, Portable, 3-DOF Wrist Rehabilitation Robot with High Physical Human–Robot Interaction. Journal of Intelligent & Robotic Systems 106:3.
Crossref
Crossref
Bita Taghizadeh, Mahmoud Reza Jaafari & Nosratollah Zarghami. (2022) New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain. Frontiers in Endocrinology 13.
Crossref
Crossref
Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, George Kollias & Petros P. Sfikakis. (2022) The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatology International 42:9, pages 1493-1511.
Crossref
Crossref
Joshua M. Tokuda, Jiansong Xie, Vibha Jawa, Jenn M. Hawkins, John Ferbas, Nathan H. Joh & Marisa K. Joubert. (2022) Use of In Vitro Human Skin Models to Assess Potential Immune Activation In Response to Biotherapeutic Attributes and Process-related Impurities. Journal of Pharmaceutical Sciences 111:4, pages 1012-1023.
Crossref
Crossref
Bob Geng & Timothy J. Craig. (2022) Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedema. Annals of Allergy, Asthma & Immunology 128:3, pages 263-268.
Crossref
Crossref
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, SangWook Yoon & Hubert Marotte. (2022) An update on the adalimumab biosimilar landscape following approval of the first high-concentration biosimilar. Immunotherapy 14:3, pages 235-252.
Crossref
Crossref
Jasvinder A. Singh, Haley Tornberg & Susan M. Goodman. (2021) Prendre un comprimé ou me faire une injection ? Point de vue des patients quant au choix des traitements de fond (DMARD) dans la polyarthrite rhumatoïde (PR). Revue du Rhumatisme 88:5, pages 362-368.
Crossref
Crossref
Hiroki Wakabayashi, Nobuto Nagao, Hitoshi Inada, Yosuke Nishioka, Masahiro Hasegawa, Kusuki Nishioka & Akihiro Sudo. (2021) Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study. Drugs in R&D 21:3, pages 351-357.
Crossref
Crossref
Madeline B. Gelb & Heather D. Maynard. (2021) Effect of Poly(trehalose methacrylate) Molecular Weight and Concentration on the Stability and Viscosity of Insulin. Macromolecular Materials and Engineering 306:9, pages 2100197.
Crossref
Crossref
Galen H. Shi, Karthik Pisupati, Jonathan G. Parker, Vincent J. Corvari, Christopher D. Payne, Wen Xu, David S. Collins & Michael R. De Felippis. (2021) Subcutaneous Injection Site Pain of Formulation Matrices. Pharmaceutical Research 38:5, pages 779-793.
Crossref
Crossref
Martin Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing & Christopher D. Saffore. (2020) Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States. Rheumatology and Therapy 8:1, pages 109-118.
Crossref
Crossref
Jasvinder A. Singh, Haley Tornberg & Susan M. Goodman. (2021) Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis. Joint Bone Spine 88:1, pages 105053.
Crossref
Crossref
David Langton, Joy Sha, Suzy Guo, Julie Sharp, Ceri Banks, Wei Wang, Virginia Plummer & Francis Thien. (2020) Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic. Respirology 25:12, pages 1243-1249.
Crossref
Crossref
Anja St Clair-Jones, Francesca Prignano, Joao Goncalves, Muriel Paul & Philipp Sewerin. (2020) Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review. Rheumatology and Therapy 7:4, pages 741-757.
Crossref
Crossref
Prodromos Sidiropoulos, Andreas Bounas, Panagiotis Athanassiou, Christos Koutsianas, Evangelia Petrikkou, Evripidis Kaltsonoudis, Alexandros Drosos & Dimitrios Vassilopoulos. (2020) Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in Greece. Clinical Rheumatology 39:12, pages 3643-3652.
Crossref
Crossref
Rituparna BhattacharyaKatie HerrenInsiya PoonawallaSuvapun BunniranAndrea BloomfieldPhil Schwab. (2020) Comparing Medical Utilization and Cost Outcomes in Oral Versus Injectable Immunotherapy Users with Chronic Inflammatory Joint and Skin Diseases. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1246-1256.
Crossref
Crossref
Naceur Rekaya, Steven M. Vicik, Bors T. Hulesch & Laura L. McDonald. (2020) Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rheumatology and Therapy 7:3, pages 537-552.
Crossref
Crossref
E. S. Aronova, G. V. Lukina, S. I. Glukhova, G. I. Gridneva & A. V. Kudryavtseva. (2020) Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up. Terapevticheskii arkhiv 92:5, pages 39-45.
Crossref
Crossref
Fausto Salaffi, Marco Di Carlo, Sonia Farah & Marina Carotti. (2020) Adherence to subcutaneous anti‐TNFα agents in patients with rheumatoid arthritis is largely influenced by pain and skin sensations at the injection site. International Journal of Rheumatic Diseases 23:4, pages 480-487.
Crossref
Crossref
Jennifer M. Fernandez, Steven Madsen, Jeffrey M. Krase & Vivian Y. Shi. (2020) Classification and mitigation of negative injection experiences with biologic medications. Dermatologic Therapy 33:2.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología 43:1, pages 9-13.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología (English Edition) 43:1, pages 9-13.
Crossref
Crossref
Arduino A. Mangoni, Fahdah Al Okaily, Hani Almoallim, Seham Al Rashidi, Reem Hamdy A. Mohammed & Amal Barbary. (2019) Relapse rates after elective discontinuation of anti-TNF therapy in rheumatoid arthritis: a meta-analysis and review of literature. BMC Rheumatology 3:1.
Crossref
Crossref
Iris Usach, Rafael Martinez, Teodora Festini & José-Esteban Peris. (2019) Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances in Therapy 36:11, pages 2986-2996.
Crossref
Crossref
Stanley Cohen, Ahmed Samad, Elaine Karis, Bradley S. Stolshek, Mona Trivedi, Hao Zhang, Girish A. Aras, Greg Kricorian & James B. Chung. (2019) Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial. Rheumatology and Therapy 6:2, pages 245-254.
Crossref
Crossref
Noemí Martínez-López De Castro, Marisol Samartín- Ucha, Alicia Martín-Vila, Miriam Álvarez-Payero, Guadalupe Piñeiro-Corrales & José M Pego-Reigosa. (2019) Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study. European Journal of Hospital Pharmacy 26:3, pages 124-128.
Crossref
Crossref
Tanja S. Jørgensen, Marie Skougaard, Peter C. Taylor, Hans C. Asmussen, Anne Lee, Louise Klokker, Louise Svejstrup, Irina Mountian, Henrik Gudbergsen & Lars Erik Kristensen. (2018) The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases. The Patient - Patient-Centered Outcomes Research 11:5, pages 515-526.
Crossref
Crossref
Ling Jia Goh & Xiaoli Zhu. (2018) Exploring Patient and Caregiver Perceptions of Primary Healthcare Sector Home Care for Simple Acute Wounds. Advances in Skin & Wound Care 31:8, pages 348-360.
Crossref
Crossref
Raphael J. Dehoratius, Lawrence H. Brent, Jeffrey R. Curtis, Lorie A Ellis & Kezhen L. Tang. (2018) Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept. The Patient - Patient-Centered Outcomes Research 11:3, pages 361-369.
Crossref
Crossref
Nicholas Warne, Bryan Balthazor & William Parr. 2018. Challenges in Protein Product Development. Challenges in Protein Product Development
561
578
.
Cristina Scavone, Liberata Sportiello, Maria G. Sullo, Carmen Ferrajolo, Rosanna Ruggiero, Maurizio Sessa, Pasquale M. Berrino, Gabriella di Mauro, Liberato Berrino, Francesco Rossi, Concetta Rafaniello & Annalisa Capuano. (2017) Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study. Frontiers in Pharmacology 8.
Crossref
Crossref
Hiroki Wakabayashi, Hitoshi Inada, Yosuke Nishioka, Masahiro Hasegawa, Akihiro Sudo & Kusuki Nishioka. (2016) Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors. Clinical Rheumatology 36:4, pages 941-946.
Crossref
Crossref
Anat Fisher, Ken Bassett, Gautam Goel, Dana Stanely, M. Alan Brookhart, Hugh R. Freeman, James M. Wright & Colin R. Dormuth. (2016) Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis. PLOS ONE 11:12, pages e0168005.
Crossref
Crossref
Ruth I. Hart, Janet E. McDonagh, Ben Thompson, Helen E. Foster, Lesley Kay, Andrea Myers & Tim Rapley. (2016) Being as Normal as Possible: How Young People Ages 16-25 Years Evaluate the Risks and Benefits of Treatment for Inflammatory Arthritis. Arthritis Care & Research 68:9, pages 1288-1294.
Crossref
Crossref
Tais Freire Galvao, Ivan Ricardo Zimmermann, Licia Maria Henrique da Mota, Marcus Tolentino Silva & Mauricio Gomes Pereira. (2016) Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 35:7, pages 1659-1668.
Crossref
Crossref
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Maurizio Benucci, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Serena Guiducci, Silvia Bellando-Randone, Marco Matucci-Cerinic, Rosario Foti, Marcella Di Gangi, Marta Mosca, Chiara Tani, Fabrizio Palmieri & Delia Goletti. (2016) Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism 45:5, pages 519-532.
Crossref
Crossref
Fausto Salaffi, Marina Carotti, Marco Di Carlo, Sonia Farah & Marwin Gutierrez. (2015) Adherence to Anti–Tumor Necrosis Factor Therapy Administered Subcutaneously and Associated Factors in Patients With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 21:8, pages 419-425.
Crossref
Crossref